💊 Lupin gets an FDA nod, and an FDA rebuke; Bharat Biotech plans a Mexican sojourn
It’s been slow days this week, particularly on the life sciences news front. Maybe it’s the heat. Maybe a certain cosmetic brand.
In today’s Kable: the WHO counters India; Lupin gets a green light from the US FDA and also a red signal; Big Brother gets big bucks for Blue Spark; ASHRAE wants your comments.
Keep reading with a 7-day free trial
Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.